• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole (CAS No. 192696-36-9): A Multifaceted Compound in Modern Pharmaceutical Research

6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole, also known by its CAS number 192696-36-9, represents a significant advancement in the field of medicinal chemistry. This compound belongs to the benzodiazole family, which is characterized by a six-membered ring fused with a five-membered ring containing nitrogen atoms. The structural features of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole include a methoxy group at the 6-position and a branched propyl substituent at the 2-position, which contribute to its unique pharmacological profile.

Recent studies have highlighted the potential of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole in modulating various biological pathways. For instance, a 2023 publication in Journal of Medicinal Chemistry demonstrated its ability to inhibit the activity of specific enzymes involved in neurodegenerative diseases. This finding underscores the importance of 6-Methoxy-2-(propan,2-yl)-1H-1,3-benzodiazole as a candidate for therapeutic applications in conditions such as Alzheimer's disease.

The synthesis of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole has been optimized through advanced organic reactions. Researchers have employed catalytic methods to enhance the yield and purity of this compound. These improvements are critical for ensuring the compound's efficacy in preclinical and clinical studies. The structural stability of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole under various conditions is another key factor in its potential for pharmaceutical development.

Pharmacological studies on 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole have revealed its interactions with multiple targets. In vitro experiments have shown that this compound can bind to specific receptors, modulating cellular responses. The mechanism of action of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole is currently under investigation, with a focus on its impact on signaling pathways associated with inflammation and oxidative stress.

Recent advancements in drug delivery systems have opened new avenues for the application of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole. Nanotechnology-based approaches are being explored to enhance the bioavailability and targeted delivery of this compound. These innovations are crucial for improving the therapeutic outcomes of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole in various disease models.

Comprehensive safety assessments of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole are essential for its development as a therapeutic agent. Toxicological studies have indicated that this compound exhibits low toxicity at therapeutic doses, making it a promising candidate for further clinical evaluation. The safety profile of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole is being continuously monitored to ensure its suitability for human use.

Collaborative efforts between academia and industry are driving the research on 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole. These partnerships are facilitating the translation of laboratory findings into practical applications. The integration of computational methods with experimental studies is accelerating the discovery of new therapeutic uses for this compound.

Environmental and ethical considerations are also being addressed in the research on 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole. Sustainable synthesis methods are being developed to minimize the ecological impact of its production. These efforts align with the growing emphasis on green chemistry in pharmaceutical research.

Emerging technologies such as artificial intelligence are being utilized to predict the behavior of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole in complex biological systems. Machine learning models are helping researchers identify potential interactions and optimize the compound's properties for specific therapeutic applications.

The global research community is actively engaged in the study of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole. International collaborations are fostering the exchange of knowledge and resources, which is vital for advancing the understanding of this compound's potential. These collaborative efforts are expected to lead to breakthroughs in the treatment of various diseases.

In summary, 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole represents a promising area of research in medicinal chemistry. Its unique structural features and potential therapeutic applications make it a valuable candidate for further investigation. As research continues to evolve, the role of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole in the development of new therapies is likely to expand, offering new possibilities for treating a wide range of diseases.

For more information on the latest research and developments related to 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole, it is recommended to consult recent scientific publications and industry reports. These resources provide insights into the current state of research and future directions in this field.

Overall, the study of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole continues to be a dynamic and exciting area of research. The interdisciplinary approach involving chemistry, biology, and technology is driving innovation and expanding the possibilities for therapeutic applications. As the field progresses, the impact of 6-Methoxy-2-(propan-2-yl)-1H-1,3-benzodiazole on human health is expected to grow, offering new solutions for medical challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)